Specifically, FGFR3‐TACC3 translocations occur predominantly in HPV‐positive HNSCC, whereas FGFR3 amplification occurs in HPV‐negative HNSCC and FGFR3 mutations occur in both. This evidence concerns the gene TACC3 and head and neck squamous cell carcinoma.